Injectable Fillers : Facial Shaping and Contouring.
Material type:
- text
- computer
- online resource
- 9781119046967
- RD119.5.F33 .I554 2019
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- About the Companion Website -- 1 Injection Anatomy: Avoiding the Disastrous Complication -- 1.1 Injection Anatomy Defined -- 1.2 Pathogenesis of Vascular Obstruction -- 1.3 The Forehead -- 1.4 The Temple -- 1.5 The Middle and Lower Face -- 1.6 Conclusion -- References -- 2 The Mathematics of Facial Beauty -- 2.1 BeautiPHIcation™: Optimizing Patient Experience and Outcomes -- 2.2 Beauty Defined -- 2.3 The Golden Ratio (Phi) -- 2.4 Reflecting on Light -- 2.5 The BeautiPHIcation Aesthetic Consult -- 2.6 Changes in Beauty with Ageing -- 2.7 Facial Assessment and Treatment Planning -- 2.8 The Upper 1/3 of the Face -- 2.9 The Middle 1/3 of the Face -- 2.10 The Lower 1/3 of the Face -- 2.11 Conclusion -- References -- 3 The Temple and Forehead -- 3.1 The Forehead -- 3.1.1 Anatomy -- 3.1.2 Injection Protocol -- 3.1.3 Safety Considerations -- 3.2 The Temples -- 3.2.1 Anatomy -- 3.2.2 Injection Protocol -- 3.2.3 Safety Considerations -- 3.3 Conclusions -- References -- 4 The Eyebrow Revisited -- 4.1 Introduction -- 4.2 Eyebrow Ageing -- 4.3 Eyebrow Aesthetics -- 4.4 Eyebrow Treatment Revisited -- 4.5 Summary -- References -- 5 Periorbital Rejuvenation -- 5.1 The Aesthetic Periorbital Complex -- 5.2 Periorbital Anatomy -- 5.3 Pathophysiology of Periorbital Ageing -- 5.4 Enhancing the Periorbital Region -- 5.5 Consultation and Assessment -- 5.6 Injection Rationale -- 5.6.1 Treatment of the Tear Trough (Medial Canthus to Medial Iris) -- 5.6.2 Treatment of the Lateral Infraorbital Crescent and Lateral Canthus -- 5.6.3 Treatment of the Nasojugal Groove -- 5.6.4 Treatment of the Infrabrow Hollow -- 5.6.5 Combination with Other Treatments -- 5.7 Conclusion -- References -- 6 The Midface and Cheeks -- 6.1 Background -- 6.2 Age-related Lipoatrophy of the Midface and Cheeks.
6.3 HIV Lipoatrophy -- 6.4 Treatment Planning -- 6.5 Injection Techniques and Safety Considerations -- 6.6 Filling Agents -- 6.6.1 Juvederm Voluma XC -- 6.6.2 Restylane Lyft -- 6.6.3 Radiesse -- 6.6.4 Sculptra® -- 6.6.5 Autologous Fat Transfer -- 6.6.6 Silicone -- 6.7 Conclusions -- References -- 7 Injection Rhinoplasty - Aesthetic Considerations and the Anatomical Basis for Safe Injection Techniques -- 7.1 Introduction -- 7.1.1 Aesthetic Considerations of Nasal Augmentation -- 7.2 Historical Context -- 7.3 The Anatomical Basis for Safe Injections -- 7.4 Indications -- 7.5 Pain Relief -- 7.6 Injection Technique -- 7.6.1 The Six-Point Injection Technique for the Nose (Very Safe) -- 7.6.2 The Eight-Point Injection Technique for the Nose (Safe but may Have Risks) -- 7.6.3 The Ten-Point Injection Technique for the Nose (Has More Risks) -- 7.7 Ten Tips for Good Injection Outcomes -- References -- 8 The Lips -- 8.1 Introduction -- 8.2 In Search of Beautiful Proportions -- 8.2.1 Ethnic Variations -- 8.3 The Ageing Lip -- 8.4 History of Lip Augmentation -- 8.5 Revitalization of the Lips -- 8.5.1 Filler Options -- 8.5.2 Needles, Cannulas, and Anaesthesia -- 8.5.3 Treatment Approach: Shape and Support -- 8.6 Combination Therapy -- 8.6.1 Botulinum Toxin -- 8.6.2 Resurfacing and Energy‐based Therapies -- 8.7 Side Effects and Complications -- 8.8 Conclusion -- References -- 9 The Mandible, Jawline, and Chin -- 9.1 Introduction -- 9.2 Regional Anatomy -- 9.3 Aesthetic Ideals -- 9.4 Treatment Modality and Product Choice -- 9.5 Injection Technique -- 9.5.1 Mandible and Jaw Line -- 9.5.2 Chin Augmentation -- 9.6 Post-procedure Care -- 9.7 Potential Complications -- 9.8 Conclusion -- References -- 10 Submental Contouring -- 10.1 Overview of ATX-101 for Submental Contouring -- 10.1.1 Mechanism of Action of ATX-101.
10.1.2 Pharmacology, Pharmacokinetics, and Pharmacodynamics of ATX-101 -- 10.1.3 Dose Optimization of ATX-101 for Submental Contouring -- 10.1.4 Efficacy and Safety of ATX-101 in Phase 3 Trials -- 10.1.5 Long-term Efficacy and Safety of ATX-101 -- 10.2 Considerations for ATX-101 Treatment in Clinical Practice -- 10.2.1 Patient Selection and Evaluation -- 10.2.2 Anatomy of the Submental Region -- 10.2.3 ATX-101 Injection Technique -- 10.2.4 Administration of ATX-101 Treatment -- 10.2.5 Patient Management -- 10.3 Summary -- 10.3.1 Clinical Pearls -- 10.4 Acknowledgement -- References -- 11 Avoidance and Management of Complications -- 11.1 Introduction -- 11.2 Early Injection Site Reactions -- 11.3 Technique and Placement Related Complications -- 11.4 Delayed Nodules -- 11.5 Vascular -- 11.5.1 Vascular Anatomy -- 11.5.2 Prevention -- 11.5.3 Treatment -- 11.6 Conclusion -- References -- Index -- EULA.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
There are no comments on this title.